Corus Pharma

Developer of therapeutics for severe respiratory diseases

placeSeattle, Washington, United States calendar_todayFounded 2001 language coruspharma.com

Innovation

14 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy, Emerging technologies; filing pace slowing. Cited 401 times.

YearFilings
20123
20132
20142
20151
20171
20211

Investor mix

18 investors on record; 2 have since exited.

Investor typeCountShare
Venture capital844%
Private equity16%
Bank & private debt211%
Other / undisclosed739%
Coming soon